Jan 21, 2021 · The IsoPSA test is a novel prostate-specific antigen assay for patients with a PSA > 4ng/ml who are facing a decision on prostate biopsy. Listen as Dr. Klein discusses how the …

IsoPSA® - IsoPSA is a structure-based (rather than concentration- based) assay that interrogates the entire spectrum of structural changes to PSA (or isoforms), and can effectively differentiate …

IsoPSA is a blood test for men with elevated total PSA ≥ 4ng/mL that identifies structural differences in PSA proteins that are expressed by cancer. IsoPSA can clarify prostate cancer …

May 9, 2022 · The results showed that in men with total PSA ≥4 ng/ml, IsoPSA led to a 55% (284 vs 638) net reduction in prostate biopsy recommendations. Further, there was also a 9% …

Dec 14, 2021 · The difference between conventional PSA and the new IsoPSA test has to do with the 3-dimensional molecular form of the PSA protein molecules. A traditional PSA test is a …

Jul 7, 2020 · Designed to stratify risk of biologically significant prostate cancer (Gleason grade > 7 prostate cancer), IsoPSA is intended to be used in men who are age 50 and older with a total …

Jun 23, 2024 · IsoPSA is a blood test that's indicated for men over 50 years old with a PSA greater than 4 ng/mL. It's meant to be an adjuvant marker for an abnormal PSA. IsoPSA does …

The short answer is that IsoPSA has been shown to be superior to traditional tests, such as PSA, total PSA, and percent free PSA, in predicting high-grade prostate cancer. As such, it has the …

May 20, 2022 · Results of a new study show that IsoPSA, a novel prostate-specific antigen assay, is readily adopted by practitioners in various practice settings, and its use significantly reduces …

Improving cancer decisions - Cleveland Diagnostics offers novel, more accurate testing for early detection of cancer and risk of high-grade disease.